As of June 12, 2025, Clearpoint Neuro Inc (CLPT) reports a Gross Margin of 60.92%.
Gross Margin indicates the portion of sales revenue remaining after covering production costs, highlighting operational efficiency.
Historical Trend of Clearpoint Neuro Inc's Gross Margin
Over recent years, Clearpoint Neuro Inc's Gross Margin has shown a stable trend. The table below summarizes the historical values:
| Date | Gross Margin |
|---|---|
| 2024-12-31 | 60.92% |
| 2023-12-31 | 56.83% |
| 2022-12-31 | 65.84% |
| 2021-12-31 | 69.26% |
| 2020-12-31 | 71.08% |
This slight downward trend highlights how Clearpoint Neuro Inc manages its operational efficiency and pricing power over time.
Comparing Clearpoint Neuro Inc's Gross Margin to Peers
To better understand Clearpoint Neuro Inc's position, it's useful to compare its Gross Margin against industry peers. Below are selected comparisons:
| Company | Gross Margin |
|---|---|
| Clearpoint Neuro Inc (CLPT) | 60.92% |
| BioSig Technologies Inc (BSGM) | 100.00% |
| Edwards Lifesciences Corp (EW) | 79.46% |
| IRadimed Corp (IRMD) | 76.94% |
| Milestone Scientific Inc (MLSS) | 74.56% |
| Co-Diagnostics Inc (CODX) | 74.48% |
Compared to its competitors, Clearpoint Neuro Inc's Gross Margin is about average compared to peers, indicating industry-standard operational efficiency.